An anti-inflammatory drug candidate, known as 3,6′-dithiopomalidomide (DP) and designed by researchers at the National Institute on Aging (NIA), protected lab mice against cognitive decline by reducing brain inflammation. An international research team led by the NIA scientists has published their findings in Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association.
Study: New drug candidate reduced brain inflammation, protected against cognitive decline in Alzheimer’s mouse model
An anti-inflammatory drug candidate, known as 3,6'-dithiopomalidomide (DP) and designed by researchers at the National Institute on Aging (NIA), protected lab mice against cognitive decline by reducing brain inflammation. An international research team led by the NIA scientists has published their findings in Alzheimer's and Dementia: The Journal of the Alzheimer's Association.